ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 62 filers reported holding ASTRIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $462,095 | -37.4% | 61,943 | -30.1% | 0.01% | -31.2% |
Q2 2023 | $738,529 | -60.5% | 88,659 | -37.0% | 0.02% | -57.9% |
Q1 2023 | $1,870,286 | -7.6% | 140,623 | +3.5% | 0.04% | -19.1% |
Q4 2022 | $2,023,879 | +120.2% | 135,922 | +33.8% | 0.05% | +104.3% |
Q3 2022 | $919,000 | +304.8% | 101,619 | +34.1% | 0.02% | +283.3% |
Q2 2022 | $227,000 | – | 75,773 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 1,347,088 | $17,916,270 | 9.94% |
Fairmount Funds Management LLC | 1,901,397 | $25,288,580 | 4.35% |
Ikarian Capital, LLC | 869,390 | $11,562,887 | 2.62% |
Affinity Asset Advisors, LLC | 529,369 | $7,040,608 | 2.32% |
Logos Global Management LP | 1,044,960 | $13,897,968 | 1.99% |
Ghost Tree Capital, LLC | 450,000 | $5,985,000 | 1.77% |
Vivo Capital, LLC | 1,681,199 | $22,359,947 | 1.55% |
Opaleye Management Inc. | 302,000 | $4,096,400 | 1.23% |
Tri Locum Partners LP | 275,011 | $3,657,646 | 1.11% |
Saturn V Capital Management LP | 101,339 | $1,347,809 | 1.01% |